These days, Biotherapeutics are the rapidly growing group of pharmaceuticals, actually for a treatment option, a variety of chronic and sometimes life-threatening conditions. Those represent a dissimilar group of biological preparations that widely encompasses nucleic acids, proteins, whole cells, viral particles, and vaccines.
In recent years, great progress has been made regarding the development of safe and effective Biotherapeutics, and in the adoption of cost-effective, more efficient, and modernized manufacturing processes. This trend looks forward to accelerating in the forthcoming years, as emerging fields related to advanced therapies or personalized medicine mature.
Advances in Drug Discovery and Development
Any Procedure which is applied to drug discovery and development by the medical community and pharmaceutical industry has a direct change in the further availability of better, innovative, and therapeutic treatment for patients with cancer. Drug discovery is defined as a complicated learning technique whereby research efforts are directed towards discover and assimilating new innovative thoughts to produce a drug to provide a benefit to a patient population.
Subsequently, a highly useful technology or approach to drug discovery should give both effective thoughts and the applications of newly discovered observations that can be utilized for therapeutic benefit.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico